Samer Saiedy, MD
Vascular Surgery · Lutherville, MDNPI 1326159864
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Philips North America LLC at 27.6% of the total. 2025 is the largest year on record at $2,599, 5.8 times the $451 reported in 2019.
Across 146 payments — averaging $49.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$2K
- Medtronic$2K
- Bard Peripheral Vascular, Inc.$1K
- Boston Scientific$391
- Terumo Medical Corporation$309
- Johnson & Johnson$246
- plus $1K from 10 others
What the payments were for
- Food & beverage$7,201100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 38 | $1,987 |
| Medtronic(2 entities) | 52 | $1,719 |
| Bard Peripheral Vascular, Inc. | 14 | $1,495 |
| Boston Scientific | 8 | $391 |
| Terumo Medical Corporation | 5 | $309 |
| Johnson & Johnson | 18 | $246 |
| Canon Medical Systems USA, Inc. | 2 | $229 |
| Aroa Biosurgery Incorporated | 1 | $197 |
| Mindray DS USA, Inc. | 1 | $153 |
| Penumbra, Inc. | 1 | $135 |
| Abbott | 1 | $130 |
| Silk Road Medical, Inc. | 1 | $107 |
| BD | 1 | $46 |
| AbbVie | 1 | $31 |
| Pfizer | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (5028) IGT Devices Systems Undivided$768
- RotarexS 6 F x 135 cm$581
- LifeStent Solo Vascular Stent$365
- Abre$322
- HawkOne$260
- Turbo Elite$214
- TE7 MAX$153
- TE X$153
- INTERVENTIONAL ANGIOGRAPHY SYSTEM$138
- Indigo$135
- AngioJet Ultra 5000A$131
- Diamondback Peripheral$130
- Fluency Endovascular Stent Graft$123
- TurboHawk$122
- JETSTREAM$109
- (6576) Laser service and other$107
- ENROUTE Transcarotid Stent$107
- ENHANCE Transcarotid Peripheral Access Kit$107
- ENROUTE Transcarotid Neuroprotection System$107
- ENROUTE .014 Guidewire$107
How this compares
$7,201 in reported general payments places this provider in the 70th percentile of 104 vascular surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 96 | $104,373 |
| EliquisApixaban | 33 | $26,657 |
| ClopidogrelClopidogrel Bisulfate | 616 | $8,467 |
| Clindamycin Hcl | 233 | $298 |
| Tramadol Hcl | 42 | $155 |
| Cephalexin | 12 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $57 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $246 | $104,37396 claims |
| PfizerEliquis | $14 | $26,65733 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 104 vascular surgery providers in Maryland.
Other vascular surgery in Lutherville
- Paul McNeillFrederick$302K
- John MartinAnnapolis$172K
- Caitlin HicksBaltimore$88K
- Shahab ToursavadkohiBaltimore$76K
- Michael OsgoodBel Air$57K
- Jeffrey WangGermantown$53K
- Frank CriadoBaltimore$52K
- Dustin YoonGermantown$36K
- Micah GirottiBel Air$35K
- Khanjan NagarshethBaltimore$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.